Modra

Modra Pharmaceuticals designs and develops oral formulations of commonly used anti-cancer drugs that currently are only available in intravenous (IV) forms.

Switching from IV-to-oral treatment reduces side effects, increases patient convenience, and leads to a reduction of healthcare costs.

Learn more

News

Phase I ModraDoc006/r presented
Read more

the IV to Oral switch

improving patient lives
Learn more

Events

Read more